New Lundbeck Foundation investment is first taste of changed strategy
The Danish foundation was part of the consortium, which also included Kirk Kapital and ATP, that acquired Ferrosan Medical Devices last week, bringing the fund one step closer to realizing its goal of having invested in a handful of healthcare companies by 2030.
by christopher due karlsson, translated by daniel pedersen
It took almost two years before the Lundbeck Foundation dipped its toes in the investment waters under a new strategy, after a strategical shift was announced by CEO Lene Skole back in December 2020.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.